MALLINCKRODT PHARMACEUTICALS

H.P. ACTHAR

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

MALLINCKRODT PHARMACEUTICALS

H.P. Acthar HCPCS:

J0801

HCPCS Code Descriptor:

Injection, corticotropin (acthar gel), up to 40 units

Category:

J Code

H.P. Acthar NDCs:

63004-8710-01

Primary Type:

Corticosteroid

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intramuscular or Subcutaneous

H.P. Acthar CPT Codes:

Potential CPT administration codes for H.P. Acthar can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About H.P. Acthar:

H.P. ACTHAR is a Corticosteroid drug manufactured by Mallinckrodt and administered via the intramuscular or subcutaneous route of administration. The J Code: J0801 is aligned to the drug H.P. ACTHAR.

ACCESS PRICING AND MORE BY REGISTERING

J0801 Added Date:

October 1, 2023

J0801 Effective Date:

October 1, 2023

J0801 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of H.P. Acthar billing and coding information.
H.P. Acthar patient assistance information can be found through Acthar Patient Support at the URL: https://www.acthar.com/
H.P. ACTHAR prescribing information can be found at the link below:
Information regarding H.P. ACTHAR’s side effects can be found at MedlinePlus